SEC ownership of Regencell Bioscience Holdings Ltd

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001829667.

Comparable stake leader

Regencell (BVI) Ltd

Disclosed value leader

Yat-Gai Au

Comparable rows

35/37

Latest evidence

27 May 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
35 of 37
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Regencell (BVI) Ltd
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
27 May 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001829667
Issuer location
Hong Kong

Ownership snapshot

Top shareholders of Regencell Bioscience Holdings Ltd (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Regencell (BVI) Ltd
Disclosed value leader
Yat-Gai Au
Comparable rows
35/37
Latest evidence
27 May 2026
13D/G 3/4/5 13F Lead comparable stake: 89% 2 rows are not safely comparable across share classes. 13D/G row: Regencell (BVI) Ltd Showing 1-8 of 37 holder rows.

Quick read

Regencell (BVI) Ltd leads the comparable SEC ownership view at 89%.

35 of 37 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Regencell (BVI) Ltd's linked filing trail.
Comparable ownership Top 5
Regencell (BVI) Ltd 89%
Yat-Gai Au 89%
Margaret Hoor Han Lo 0.12%
Yat-Pui Au 0.12%
GEODE CAPITAL MANAGEMENT, LLC 0.08%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 37 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Regencell (BVI) Ltd
13D/G
Yat-Gai Au
89%
$7,461,749,817
437,896,116 shares
+$7,270,529,987 11 Jul 2025
Yat-Gai Au
3/4/5
Chief Executive Officer, Director, 10%+ Owner
89%
$11,512,288,889
437,896,116 shares
18 Mar 2026
Margaret Hoor Han Lo
3/4/5
Director
0.12%
$15,880,474
604,050 shares
18 Mar 2026
Yat-Pui Au
3/4/5
Chief Business Officer
0.12%
$15,288,003
581,514 shares
18 Mar 2026
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.08%
$10,567,919
415,569 shares
31 Mar 2026
Marex Group Ltd
13F
Company
13F
0.01%
$803,588
31,600 shares
31 Mar 2026
GSA CAPITAL PARTNERS LLP
13F
Company
13F
0.01%
$803,000
31,569 shares
31 Mar 2026
Vident Advisory, LLC
13F
Company
13F
0.01%
$752,423
29,588 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 14 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-7 of 7 reporting-owner rows connected to Regencell Bioscience Holdings Ltd. Open a relationship link for the CIK-to-CIK filing trail.

Rows
7
Largest Forms 3/4/5 holder
Yat-Gai Au
Net 12M change
$0
Latest report
27 May 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Yat-Gai Au Chief Executive Officer, Director, 10%+ Owner $11,512,288,889 Mixed 18 Mar 2026
Margaret Hoor Han Lo Director $15,880,474 Mixed 18 Mar 2026
Yat-Pui Au Chief Business Officer $15,288,003 Mixed 18 Mar 2026
William Wing Yan Dr Lo Director Mixed 27 May 2026
Ho Yau Chan Financial Controller Mixed 18 Mar 2026
James Wai Hong Chung COO and Chief Strategy Officer, Director Mixed 18 Mar 2026
Evana Yee Wah Hui Director Mixed 27 May 2026

Recent insider transactions for Regencell Bioscience Holdings Ltd

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
William Wing Yan Dr Lo RGC Stock option (right to purchase) Disposed to Issuer -11.9% -70,600 521,630 27 May 2026 Direct
Evana Yee Wah Hui RGC Stock option (right to purchase) Disposed to Issuer -3.21% -19,000 573,230 27 May 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .